AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Onconetix, Inc. Director's Dealing 2025

Mar 25, 2025

35411_dirs_2025-03-25_b90aec57-5095-4de8-82db-22c3c82503d8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconetix, Inc. (ONCO)
CIK: 0001782107
Period of Report: 2025-03-23

Reporting Person: Oakley Andrew John (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-03-23	Common Stock	A	1709	$0.00	Acquired	1709	Direct

Footnotes

F1: On March 23, 2025, the Reporting Person was granted 1,709 restricted stock units, which will be settled in shares of common stock, par value $0.00001. The restricted stock units fully vest on August 31, 2025.

F2: Includes unvested RSUs.